Form 4: CervoMed Director Sabbagh Marwan Acquires Stock Options
SEC Form 4 Filing
Director Sabbagh Marwan acquired stock options for 5,750 shares of CervoMed Inc. common stock on June 14, 2024, following election to the board.
Summary
- Marwan Sabbagh, a director of CervoMed Inc., was granted stock options to purchase 5,750 shares of the company's common stock on June 14, 2024.
- The options were granted in connection with Sabbagh's election to the Issuer's board of directors at its 2024 Annual Meeting of Stockholders.
- The exercise price of the stock options is $19.01.
- The options vest monthly over a one-year period, starting June 30, 2024, contingent upon continued service as a director.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The granting of stock options is a standard practice and suggests confidence in the company's future performance. The vesting schedule aligns director interests with long-term shareholder value.
Positives
- The granting of stock options to a director aligns their interests with those of the shareholders.
- The vesting schedule incentivizes continued service and commitment to the company.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedule of the stock options.
Industry Context
Granting stock options to board members is a common practice to align their interests with shareholders and incentivize long-term value creation. The specific terms of the grant, such as the vesting schedule and exercise price, are typical for director compensation packages.
Comparison to Industry Standards
- Director compensation packages often include stock options or restricted stock units to align director interests with shareholder value.
- Vesting schedules for director equity awards typically range from one to three years, with monthly or quarterly vesting being common.
- The exercise price of $19.01 is relevant to the market price of CervoMed's stock at the time of the grant, which would determine the potential value of the options to the director.
Stakeholder Impact
- Shareholders may view the granting of stock options positively as it aligns director interests with shareholder value.
- The director is incentivized to contribute to the company's success to maximize the value of their stock options.
Key Dates
| Date | Description |
|---|---|
| 06/14/2024 | Date of earliest transaction: Grant of stock options to Marwan Sabbagh. |
| 06/14/2024 | Marwan Sabbagh elected to the Issuer's board of directors at its 2024 Annual Meeting of Stockholders. |
| 06/30/2024 | Start date for monthly vesting of stock options. |
| 06/14/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.